GLP-1 Drugs Linked to 30% Lower Breast Cancer Risk in New Study
By
Omer Awan
A five-star bake. Worth schmearing, sharing, saving.
Summary
New research published in the Journal of Clinical Oncology suggests GLP-1 weight loss medications may reduce cancer risk. An observational study of over 200,000 mammograms found women taking GLP-1 drugs were 30% less likely to develop breast cancer. Additional research on over 10,000 patients indicates these drugs may also slow progression of existing cancers. A medical expert discusses the potential public health implications of these findings.
Key quotes
· 3 pulledThose that took GLP-1 medications were 30% less likely to develop breast cancer compared to women that didn't take the drugs.
These drugs have been shown not only to decrease the risk of development of cancer, but also decrease progression of known cancers.
New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the future.
You might also wanna read
Study Finds GLP-1 Drugs Associated with 58% Lower Mortality in Colon Cancer Patients
A study analyzing over 6,800 colon cancer patients across University of California Health sites found that patients taking GLP-1 medications
Study: Stopping GLP-1 Drugs Increases Heart Attack and Stroke Risk
New research published in BMJ Medicine reveals that stopping GLP-1 drugs (originally for diabetes, now popular for weight loss) leads to a r
nautil.us·2mo ago
Study: Most Patients Regain Weight and Lose Health Benefits After Stopping GLP-1 Drugs
A study on tirzepatide (a GLP-1 drug) found that after stopping the medication, 82% of participants regained at least 25% of the weight they
arstechnica.com·6mo ago
GLP-1 Therapy Reduces Migraine Frequency by More Than Half in Obesity Patients
A study from the University of Naples found that liraglutide, a GLP-1 receptor agonist typically used for diabetes and obesity, significantl
medlink.com·6mo ago
GLP-1 Medications Show Promise for Treating Addiction Through Brain Reward Pathways
The article explores the emerging potential of GLP-1 medications like Ozempic to treat various addictions beyond their original diabetes and
newyorker.com·4mo ago
What Happens When You Stop Taking GLP-1 Weight Loss Medications
This article examines the experiences of people who stop taking GLP-1 weight loss medications (like Ozempic and Wegovy), exploring what happ
bbc.com·5mo ago